VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.370
-0.004 (-1.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.366
-0.004 (-1.19%)
After-hours: Dec 5, 2025, 7:38 PM EST
VYNE Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 12 | 49 | 33 | 9 | 55 | 265 | |
| Market Cap Growth | -69.31% | 51.96% | 273.57% | -84.05% | -79.42% | - | |
| Enterprise Value | -20 | -21 | 17 | -27 | 3 | 224 | |
| Last Close Price | 0.37 | 3.35 | 2.33 | 2.70 | 18.36 | 113.76 | |
| PS Ratio | 30.15 | 98.64 | 76.70 | 18.25 | 58.63 | 12.64 | |
| PB Ratio | 0.37 | 0.95 | 0.37 | 0.28 | 1.12 | 7.08 | |
| P/TBV Ratio | 0.38 | 0.95 | 0.37 | 0.28 | 1.12 | 7.08 | |
| EV/Sales Ratio | - | - | 40.27 | - | 3.58 | 10.69 | |
| Debt / Equity Ratio | - | 0.00 | 0.00 | - | 0.01 | 0.93 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.24 | |
| Inventory Turnover | - | - | - | - | - | 0.32 | |
| Quick Ratio | 8.09 | 4.15 | 12.37 | 3.84 | 2.71 | 3.42 | |
| Current Ratio | 8.87 | 4.35 | 12.73 | 4.10 | 3.43 | 4.01 | |
| Return on Equity (ROE) | -70.67% | -56.54% | -46.40% | -84.81% | -102.66% | -928.19% | |
| Return on Assets (ROA) | -41.51% | -33.14% | -26.42% | -39.77% | -30.25% | -81.10% | |
| Return on Capital (ROIC) | -48.70% | -38.65% | -30.39% | -53.32% | -40.11% | -114.09% | |
| Return on Capital Employed (ROCE) | -116.20% | -83.80% | -32.50% | -109.20% | -80.00% | -157.70% | |
| Earnings Yield | -273.37% | -80.61% | -87.49% | -266.62% | -134.33% | -96.35% | |
| FCF Yield | -312.41% | -68.98% | -77.92% | -335.43% | -103.26% | -51.72% | |
| Buyback Yield / Dilution | -7.39% | -314.57% | -222.44% | -11.44% | -58.75% | -282.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.